Qnostics
is part of the BBI Holdings Plc group of companies.
Products
& Services
A
rapid increase in the use of molecular tests for routine clinical
diagnosis together with the complex nature of nucleic acid
testing means it is essential that these tests are fully controlled
to ensure optimal patient management is achieved.
Qnostics' product and service portfolio consists of a wide
range of highly characterized, clinically relevant panels
that enable clinical laboratories as well as assay manufacturers
to monitor and evaluate their chosen molecular technology.